New anti-inflammatory targets for chronic obstructive pulmonary disease

PJ Barnes - Nature reviews Drug discovery, 2013 - nature.com
Chronic obstructive pulmonary disease (COPD) is associated with chronic inflammation of
the peripheral airways and lung parenchyma, which leads to progressive obstruction of the …

Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis

F Piehl - Journal of Internal Medicine, 2021 - Wiley Online Library
The treatment of multiple sclerosis (MS), the most common chronic inflammatory,
demyelinating and neurodegenerative disease of the central nervous system (CNS) …

[HTML][HTML] The Keap1–Nrf2 system in cancers: stress response and anabolic metabolism

Y Mitsuishi, H Motohashi, M Yamamoto - Frontiers in oncology, 2012 - frontiersin.org
The Keap1–Nrf2 [Kelch-like ECH-associated protein 1–nuclear factor (erythroid-derived 2)-
like 2] pathway plays a central role in the protection of cells against oxidative and xenobiotic …

[HTML][HTML] Disease-modifying therapies and infectious risks in multiple sclerosis

A Winkelmann, M Loebermann, EC Reisinger… - Nature Reviews …, 2016 - nature.com
Immunomodulatory and immunosuppressive treatments for multiple sclerosis (MS) are
associated with an increased risk of infection, which makes treatment of this condition …

Targeting inflammation in diabetic nephropathy: a tale of hope

JA Moreno, C Gomez-Guerrero, S Mas… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Diabetic nephropathy (DN) is the leading cause of chronic kidney disease
(CKD) and end-stage renal disease (ESRD). Beyond the new anti-diabetic drugs that …

Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease

Z Qu, J Sun, W Zhang, J Yu, C Zhuang - Free Radical Biology and …, 2020 - Elsevier
Oxidative stress is considered as one of the pathogenesis of Alzheimer's disease (AD) and
plays an important role in the occurrence and development of AD. Nuclear factor erythroid 2 …

The mitochondria‐targeted anti‐oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance

L Kang, S Liu, J Li, Y Tian, Y Xue, X Liu - Cell proliferation, 2020 - Wiley Online Library
Objective Mitochondrial dysfunction, oxidative stress and nucleus pulposus (NP) cell
apoptosis are important contributors to the development and pathogenesis of intervertebral …

The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history

PS Sorensen, F Sellebjerg, HP Hartung, X Montalban… - Brain, 2020 - academic.oup.com
In the past decade, changes have occurred in the spectrum of multiple sclerosis courses.
The natural history of multiple sclerosis appears milder from the first sign of demyelinating …

[HTML][HTML] The Nrf2 pathway in ischemic stroke: a review

M Farina, LE Vieira, B Buttari, E Profumo, L Saso - Molecules, 2021 - mdpi.com
Ischemic stroke, characterized by the sudden loss of blood flow in specific area (s) of the
brain, is the leading cause of permanent disability and is among the leading causes of death …

Depression in multiple sclerosis: epidemiology, aetiology, diagnosis and treatment

C Solaro, G Gamberini, FG Masuccio - CNS drugs, 2018 - Springer
Depressive disorders are common in patients with multiple sclerosis, influencing their quality
of life and adherence to treatments, as well as becoming more frequent with the progression …